---
document_datetime: 2025-11-19 11:42:07
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/remsima-epar-all-authorised-presentations_en.pdf
document_name: remsima-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.8287957
conversion_datetime: 2025-12-31 01:22:52.424756
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## MA (EU) number (Invented) name Strength Pharmaceutical Form Route of Administrati Immediate Packaging Content (concentration) Pack size

on EU/1/13/853/001 Remsima 100 mg Powder for concentrate for solution for infusion Intravenous use vial (glass) 1 vial EU/1/13/853/002 Remsima 100 mg Powder for concentrate for solution for infusion Intravenous use vial (glass) 2 vials EU/1/13/853/003 Remsima 100 mg Powder for concentrate for solution for infusion Intravenous use vial (glass) 3 vials EU/1/13/853/004 Remsima 100 mg Powder for concentrate for solution for infusion Intravenous use vial (glass) 4 vials EU/1/13/853/005 Remsima 100 mg Powder for concentrate for solution for infusion Intravenous use vial (glass) 5 vials EU/1/13/853/006 Remsima 120 mg Solution for injection Subcutaneous use pre-filled syringe (glass) 1 ml (120 mg/ml) 1 pre-filled syringe + 2 alcohol pads EU/1/13/853/007 Remsima 120 mg Solution for injection Subcutaneous use pre-filled syringe (glass) 1 ml (120 mg/ml) 2 pre-filled syringes + 2 alcohol pads EU/1/13/853/008 Remsima 120 mg Solution for injection Subcutaneous use pre-filled syringe (glass) 1 ml (120 mg/ml) 4 pre-filled syringes + 4 alcohol pads EU/1/13/853/009 Remsima 120 mg Solution for injection Subcutaneous use pre-filled syringe (glass) with automatic needle guard 1 ml (120 mg/ml) 1 pre-filled syringe + 2 alcohol pads EU/1/13/853/010 Remsima 120 mg Solution for injection Subcutaneous use pre-filled syringe (glass) with automatic needle guard 1 ml (120 mg/ml) 2 pre-filled syringes + 2 alcohol pads EU/1/13/853/011 Remsima 120 mg Solution for injection Subcutaneous use pre-filled syringe (glass) with automatic needle guard 1 ml (120 mg/ml) 4 pre-filled syringes + 4 alcohol pads EU/1/13/853/012 Remsima 120 mg Solution for injection Subcutaneous use pre-filled syringe (glass) in prefilled pen 1 ml (120 mg/ml) 1 pre-filled pen + 2 alcohol pads EU/1/13/853/013 Remsima 120 mg Solution for injection Subcutaneous use pre-filled syringe (glass) in prefilled pen 1 ml (120 mg/ml) 2 pre-filled pens + 2 alcohol pads EU/1/13/853/014 Remsima 120 mg Solution for injection Subcutaneous use pre-filled syringe (glass) in prefilled pen 1 ml (120 mg/ml) 4 pre-filled pens + 4 alcohol pads EU/1/13/853/015 Remsima 120 mg Solution for injection Subcutaneous pre-filled syringe 1 ml (120 mg/ml) 6 pre-filled syringes

<div style=\"page-break-after: always\"></div>

| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form                   | Route of Administrati on   | Immediate Packaging                                            | Content (concentration)   | Pack size                                               |
|------------------|-------------------|------------|---------------------------------------|----------------------------|----------------------------------------------------------------|---------------------------|---------------------------------------------------------|
| EU/1/13/853/016  | Remsima           | 120 mg     | Solution for injection                | use Subcutaneous use       | (glass) pre-filled syringe (glass) with automatic needle guard | 1 ml (120 mg/ml)          | + 6 alcohol pads 6 pre-filled syringes + 6 alcohol pads |
| EU/1/13/853/017  | Remsima           | 120 mg     | Solution for injection                | Subcutaneous use           | pre-filled syringe (glass) in pre- filled pen                  | 1 ml (120 mg/ml)          | 6 pre-filled pens + 6 alcohol pads                      |
| EU/1/13/853/018  | Remsima           | 40 mg/ml   | Concentrate for solution for infusion | Intravenous use            | vial (glass)                                                   | 2.5 ml                    | 1 vial                                                  |
| EU/1/13/853/019  | Remsima           | 40 mg/ml   | Concentrate for solution for infusion | Intravenous use            | vial (glass)                                                   | 2.5 ml                    | 2 vials                                                 |
| EU/1/13/853/020  | Remsima           | 40 mg/ml   | Concentrate for solution for infusion | Intravenous use            | vial (glass)                                                   | 2.5 ml                    | 3 vials                                                 |
| EU/1/13/853/021  | Remsima           | 40 mg/ml   | Concentrate for solution for infusion | Intravenous use            | vial (glass)                                                   | 2.5 ml                    | 4 vials                                                 |
| EU/1/13/853/022  | Remsima           | 40 mg/ml   | Concentrate for solution for infusion | Intravenous use            | vial (glass)                                                   | 2.5 ml                    | 5 vials                                                 |
| EU/1/13/853/023  | Remsima           | 40 mg/ml   | Concentrate for solution for infusion | Intravenous use            | vial (glass)                                                   | 8.75 ml                   | 1 vial                                                  |
| EU/1/13/853/024  | Remsima           | 40 mg/ml   | Concentrate for solution for infusion | Intravenous use            | vial (glass)                                                   | 8.75 ml                   | 2 vials                                                 |
| EU/1/13/853/025  | Remsima           | 40 mg/ml   | Concentrate for solution for infusion | Intravenous use            | vial (glass)                                                   | 8.75 ml                   | 3 vials                                                 |
| EU/1/13/853/026  | Remsima           | 40 mg/ml   | Concentrate for solution for infusion | Intravenous use            | vial (glass)                                                   | 8.75 ml                   | 4 vials                                                 |
| EU/1/13/853/027  | Remsima           | 40 mg/ml   | Concentrate for solution for infusion | Intravenous use            | vial (glass)                                                   | 8.75 ml                   | 5 vials                                                 |